DURECT Corporation Trading Halted Today; FDA Advisory Committee to Discuss POSIMIR® (bupivacaine extended-release solution) for Post-Surgical Analgesia
CUPERTINO, Calif., Jan. 16, 2020 /PRNewswire/ — DURECT Corporation (Nasdaq: DRRX) today announced that NASDAQ has halted trading of the Company’s common stock today. The U.S. Food and Drug Administration’s (FDA) Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) is…
Comments Off on DURECT Corporation Trading Halted Today; FDA Advisory Committee to Discuss POSIMIR® (bupivacaine extended-release solution) for Post-Surgical Analgesia